RxDoctor Payments Data

William Wiley, MD

Ophthalmology · Cleveland, OHNPI 1689687147

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $314,897 of the $479,196 with a category attached, or 65.7%. 34 manufacturers reported payments, led by Alcon at 32.0% of the total. Reporting peaked in 2023 at $120,893 and has fallen 65.2% since, to $42,037 in 2025. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$479,196in general payments, 2019–2025

Across 454 payments — averaging $1055.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$153K
  • Carl Zeiss Meditec, Inc.$82K
  • Beaver-visitec International, Inc.$61K
  • Glaukos Corporation$55K
  • Rxsight Inc$37K
  • Johnson & Johnson Surgical Vision, Inc.$19K
  • plus $73K from 28 others
$1,510,449in research payments, 2019–2025

Across 245 payments — averaging $6165.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rxsight Inc$385K
  • Johnson & Johnson Surgical Vision, Inc.$310K
  • Carl Zeiss Meditec, Inc.$265K
  • Bausch Health US, LLC$228K
  • Carl Zeiss Meditec Production LLC$116K
  • Bausch & Lomb Americas Inc.$105K
  • plus $101K from 1 others

What the payments were for

  • Consulting fees$314,89766%
  • Speaking & faculty fees$80,41217%
  • Travel & lodging$1,3200%
  • Food & beverage$16,2203%
  • Education$10,5452%
  • Gifts$1870%
  • Other$55,61312%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$479,196 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.

See all ophthalmology providers in Ohio

Medicare billing

Part B allowed, 2024
$622,611
Medicare patients
866
Services billed
2,899

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketorolac Tromethamine177$2,344
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha196$2,005
Latanoprost46$714
Prednisolone Acetate18$428
Brimonidine Tartrate39$275

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →